Schroder Investment Management Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-45,652
| Closed | -$853K | – | 1400 |
|
|
2021
Q4 | $853K | Sell |
45,652
-2,657
| -6% | -$49.6K | ﹤0.01% | 1056 |
|
|
2021
Q3 | $954K | Sell |
48,309
-17,195
| -26% | -$340K | ﹤0.01% | 1109 |
|
|
2021
Q2 | $1.55M | Buy |
65,504
+3,819
| +6% | +$90.3K | ﹤0.01% | 1069 |
|
|
2021
Q1 | $1.46M | Sell |
61,685
-13,449
| -18% | -$319K | ﹤0.01% | 1069 |
|
|
2020
Q4 | $1.51M | Sell |
75,134
-14,587
| -16% | -$292K | ﹤0.01% | 1051 |
|
|
2020
Q3 | $1.9M | Sell |
89,721
-10,035
| -10% | -$213K | ﹤0.01% | 896 |
|
|
2020
Q2 | $1.75M | Buy |
99,756
+23,525
| +31% | +$412K | ﹤0.01% | 844 |
|
|
2020
Q1 | $1.34M | Buy |
+76,231
| New | +$1.34M | ﹤0.01% | 864 |
|
|
2019
Q3 | – | Sell |
-19,443
| Closed | -$256K | – | 1283 |
|
|
2019
Q2 | $256K | Buy |
+19,443
| New | +$256K | ﹤0.01% | 1059 |
|